Recent Developments:
# In October 2017, Natus Medical (US) acquired Integra LifeSciences (Neurosurgery Assets) (US). As part of the transaction, Natus acquired the global Camino ICP monitoring product line, including its San Diego manufacturing facility, from Integra. The sale also includes the US rights relating to Integra's fixed pressure shunts, as well as US rights to Codman's DURAFORM dural graft implants, standard EVD catheters, and CSF collection systems.
# In March 2016, Natus Medical acquired NeuroQuest, a provider of neurodiagnostic services. This acquisition complemented its otherwise organic growth strategies and enabled the company to strengthen its brand and establish itself as a leading player in the ambulatory EEG service business.
Key Questions Addressed by the Report
# Where will all these developments take the industry in the mid- to long-term?
# What types of annual and multi-year partnerships are brain monitoring companies exploring?
# Who are the key players in the market, and how intense is the competition?
# Which are the recent contracts and agreements key players have signed?
# What are the recent trends affecting the brain monitoring market?
Please Share your Specific Interest So That We Can Serve You Better | Download PDF Brochure@
Factors Influencing Global Growth:-
Driver: Growing incidence of traumatic brain injuries
A traumatic brain injury (TBI) is non-degenerative, non-congenital damage to the brain from an external mechanical force, possibly leading to permanent or temporary impairment. TBI is a major public health concern, and the most common cause of death and disability in developed as well as developing countries.
According to the CDC, TBI is a leading cause of morbidity and mortality, responsible for 2.8 million accidents and emergency department visits annually in the US and about 1 million in the UK. It is one of the most common causes of mortality in people aged under 25, and its incidence is high in adults and very young children as well. However, the rate of TBI-related hospitalizations and deaths is the highest in the elderly. According to Headway, in 2016–2017, there were 348,453 hospital admissions related to brain injuries in the UK
TBI, if ignored, can lead to permanent disabilities or death. Close monitoring and immediate therapy for related abnormalities are crucial to reducing the rate of mortality or morbidity associated with TBIs. As ICP is the most common cause of death in patients with severe TBI, ICP monitoring is considered as the standard of care. The growing incidence of TBIs is, therefore, likely to support market growth during the forecast period.
Opportunity: Increasing Expanding therapeutic applications of brain monitoring devices
Apart from applications in neurological disorders, neurodegenerative diseases, and psychiatric disorders, brain monitoring devices are also used in other therapeutic areas like insomnia, post-traumatic stress disorder (PTSD), and sleep apnea. Quantitative EEG analysis is widely used to investigate the neurophysiological characteristics of insomnia. EEG biofeedback is a training process that has been scientifically proven to aid in the management of PTSD.
Challenge: Shortage of trained professionals
Trained medical personnel are required to effectively operate devices involved in the complex process of brain monitoring. The positioning of electrodes on the scalp and the insertion of muscular needles require accuracy and have to be performed only by highly trained personnel. In addition, the results generated by brain monitoring machines are complex and can only be interpreted by qualified technicians or skilled professionals. Without these fundamental skills, end users will face difficulties in maximizing the utility of their brain monitoring equipment. The presence of highly skilled medical personnel and staff is, therefore, vital for the effective use of brain monitoring equipment.
Please Share your Specific Interest So That We Can Serve You Better | Request Sample Pages@
Monetary Growth Expectations, Globally:
According to the Research Study conducted by MarketsandMarkets™: The global brain monitoring market is expected to reach USD 11.6 billion by 2024 from USD 8.7 billion in 2019, at a CAGR of 6.1% during the forecast period.
Geographical Growth Scenario:
“North America is expected to command the largest share of the brain monitoring market in 2019.”
On the basis of region, the global brain monitoring market is divided into North America, Europe, Asia, and the RoW. North America is expected to hold the largest share of the global brain monitoring market in 2019, while Asia is projected to be the fastest-growing region in the forecast period. Growth in the market in Asia can be attributed to the growing geriatric population, the availability of low-cost labor and skilled manpower, increase in disposable incomes, rising prevalence of neurodegenerative disorders, and increasing government emphasis on healthcare reforms in the region.
Leading Market Players:
# Advanced Brain Monitoring (US)
# Nihon Kohden Corporation (Japan)
# Natus Medical, Inc. (US)
# Philips Healthcare (Netherlands)
# GE Healthcare (US)
# Siemens Healthineers (Germany) and many more…
Read More Detailed Article@
No comments:
Post a Comment